Geneva meetings and events:
“The WHO Executive Board is composed of 34 members technically qualified in the field of health. Members are elected for three-year terms. The main Board meeting, at which the agenda for the forthcoming Health Assembly is agreed upon and resolutions for forwarding to the Health Assembly are adopted, is held in January, with a second shorter meeting in May, immediately after the Health Assembly, for more administrative matters. The main functions of the Board are to give effect to the decisions and policies of the Health Assembly, to advise it and generally to facilitate its work.”
Civil society meetings related to EB142: 19-20 January 2018
|“Sub-Saharan African countries have sustained unprecedented transformation in the last decade, including constant economic growth, a growing middle class, increased political stability, and a skilled workforce. However, challenges remain: Continuing population growth and sharp increase in youth population will increase pressure on health systems.
This event brings together emerging leaders from Ghana and Nigeria to discuss the achievements and challenges across the continent, including the most promising approaches for improving healthcare systems and the realisation of Universal Health Coverage (UHC).
18:30-18:45 Welcome and Introduction
18:45-19:45 Panel discussion
The event will be followed by a reception, and is co-organised by the Global Health Centre with Chatham House and IFPMA.”
“The Geneva Health Forum (GHF), a biennial event launched in 2006 and held in the Spring, combines plenary and parallel sessions attended by hundreds of participants, with a large international exhibition area.
Geneva University Hospitals (HUG) along with the Faculty of Medicine of the University of Geneva, and Swiss and International organizations committed to Global Health have joined their talents and resources to organize the Geneva Health Forum.
The GHF was established to link policy and practice, and addresses health issues through an integrative approach. It is known as the largest event in Europe gathering such a distinguished audience, composed of academic leaders, practitioners, policy makers, diplomats, representatives of donor agencies and healthcare providers.
Keynotes lectures and plenary sessions are given by international health leaders, and series of workshops, oral and poster sessions are held. These foster and nurture stimulating discussions on major global health issues. All plenary sessions as well as a track of parallel sessions are simultaneously translated in French and English. The GHF also provides a platform for showcasing the international and humanitarian, practice and solution-oriented commitment of the participants, and gives a voice to those active in the frontlines of global health.
Geneva provides a unique opportunity to the leading global health organizations to meet with governmental delegations appointed by most countries through their permanent UN representations. Indeed, Geneva hosts major international organizations in charge of health and humanitarian action, influential foundations, NGOs and public-private partnership organizations in the field of global health.
The Lake Geneva area, often described as the “Health Valley”, presents a unique concentration of healthcare and academic institutions, and is blooming with many innovative biotech, medtech, and engineering start-ups as well as larger companies in the health sector.
The seventh edition of GHF, will take place from April 10-12, 2018 at the International Conference Center of Geneva (CICG).”
“The World Health Assembly is the supreme decision-making body for WHO. It generally meets in Geneva in May each year, and is attended by delegations from all 194 Member States. Its main function is to determine the policies of the Organization. The Health Assembly appoints the Director-General, supervises the financial policies of the Organization, and reviews and approves the Proposed programme budget. It similarly considers reports of the Executive Board, which it instructs in regard to matters upon which further action, study, investigation or report may be required.” (Source: WHO)